B-intervention	0	10	Smartphone
I-intervention	10	11	-
I-intervention	11	18	Enabled
I-intervention	19	25	Health
I-intervention	26	34	Coaching
O	35	47	Intervention
O	48	49	(
O	49	54	iMOVE
O	54	55	)
O	56	58	to
O	59	66	Promote
O	67	71	Long
O	71	72	-
O	72	76	Term
O	77	88	Maintenance
O	89	91	of
O	92	100	Physical
O	101	109	Activity
O	110	112	in
O	113	119	Breast
O	120	126	Cancer
O	127	136	Survivors
O	136	137	:
O	138	146	Protocol
O	147	150	for
O	151	152	a
O	153	164	Feasibility
O	165	170	Pilot
O	171	181	Randomized
O	182	192	Controlled
O	193	198	Trial
O	198	199	.

O	200	208	Although
O	209	217	physical
O	218	226	activity
O	227	230	has
O	231	235	been
O	236	241	shown
O	242	244	to
O	245	255	contribute
O	256	258	to
O	259	263	long
O	263	264	-
O	264	268	term
O	269	276	disease
O	277	284	control
O	285	288	and
O	289	295	health
O	296	298	in
O	299	305	breast
O	306	312	cancer
O	313	322	survivors
O	322	323	,
O	324	325	a
O	326	334	majority
O	335	337	of
O	338	344	breast
O	345	351	cancer
O	352	361	survivors
O	362	364	do
O	365	368	not
O	369	373	meet
O	374	382	physical
O	383	391	activity
O	392	402	guidelines
O	402	403	.

O	404	408	Past
O	409	417	research
O	418	421	has
O	422	429	focused
O	430	432	on
O	433	442	promoting
O	443	451	physical
O	452	460	activity
O	461	471	components
O	472	475	for
O	476	481	short
O	481	482	-
O	482	486	term
O	487	493	breast
O	494	500	cancer
O	501	509	survivor
O	510	518	benefits
O	518	519	,
O	520	523	but
O	524	536	insufficient
O	537	546	attention
O	547	550	has
O	551	555	been
O	556	563	devoted
O	564	566	to
O	567	571	long
O	571	572	-
O	572	576	term
O	577	585	outcomes
O	586	589	and
O	590	599	sustained
O	600	608	exercise
O	609	618	adherence
O	618	619	.

O	620	622	We
O	623	626	are
O	627	636	assessing
O	637	638	a
O	639	645	health
O	646	651	coach
O	652	664	intervention
O	665	666	(
O	666	671	iMOVE
O	671	672	)
O	673	677	that
O	678	682	uses
O	683	689	mobile
O	690	700	technology
O	701	703	to
O	704	712	increase
O	713	716	and
O	717	724	sustain
O	725	733	physical
O	734	742	activity
O	743	754	maintenance
O	755	757	in
O	758	767	initially
O	768	776	inactive
O	777	783	breast
O	784	790	cancer
O	791	800	survivors
O	800	801	.

O	802	806	This
O	807	812	pilot
O	813	823	randomized
O	824	834	controlled
O	835	840	trial
O	841	842	(
O	842	845	RCT
O	845	846	)
O	847	849	is
O	850	852	an
O	853	860	initial
O	861	865	step
O	866	868	in
O	869	879	evaluating
O	880	883	the
O	884	889	iMOVE
O	890	902	intervention
O	903	906	and
O	907	911	will
O	912	918	inform
O	919	930	development
O	931	933	of
O	934	935	a
O	936	940	full
O	940	941	-
O	941	946	scale
O	947	956	pragmatic
O	957	960	RCT
O	960	961	.

O	962	964	We
O	965	969	will
O	970	976	enroll
B-total-participants	977	980	107
O	981	991	physically
O	992	1000	inactive
O	1001	1007	breast
O	1008	1014	cancer
O	1015	1024	survivors
O	1025	1028	and
O	1029	1037	randomly
O	1038	1044	assign
O	1045	1049	them
O	1050	1052	to
O	1053	1065	intervention
O	1066	1068	or
B-control	1069	1076	control
I-control	1077	1083	groups
O	1084	1086	at
O	1087	1090	the
O	1091	1101	University
O	1102	1108	Health
O	1109	1116	Network
O	1116	1117	,
O	1118	1119	a
O	1120	1128	tertiary
O	1129	1135	cancer
O	1136	1140	care
O	1141	1147	center
O	1148	1150	in
B-location	1151	1158	Toronto
I-location	1158	1159	,
I-location	1160	1166	Canada
O	1166	1167	.

O	1168	1180	Participants
O	1181	1185	will
O	1186	1188	be
O	1189	1194	women
O	1195	1196	(
O	1196	1199	age
B-age	1200	1202	18
I-age	1203	1205	to
I-age	1206	1208	74
I-age	1209	1214	years
O	1214	1215	)
B-eligibility	1216	1226	stratified
I-eligibility	1227	1229	by
I-eligibility	1230	1233	age
I-eligibility	1234	1235	(
I-eligibility	1235	1237	55
I-eligibility	1238	1243	years
I-eligibility	1244	1247	and
I-eligibility	1248	1253	older
I-eligibility	1253	1254	/
I-eligibility	1254	1261	younger
I-eligibility	1262	1266	than
I-eligibility	1267	1269	55
I-eligibility	1270	1275	years
I-eligibility	1275	1276	)
I-eligibility	1277	1280	and
I-eligibility	1281	1289	adjuvant
I-eligibility	1290	1297	hormone
I-eligibility	1298	1305	therapy
I-eligibility	1306	1307	(
I-eligibility	1307	1310	AHT
I-eligibility	1310	1311	)
I-eligibility	1312	1320	exposure
I-eligibility	1321	1322	(
I-eligibility	1322	1325	AHT
I-eligibility	1326	1328	vs
I-eligibility	1329	1331	no
I-eligibility	1332	1335	AHT
I-eligibility	1335	1336	)
I-eligibility	1337	1346	following
I-eligibility	1347	1353	breast
I-eligibility	1354	1360	cancer
I-eligibility	1361	1370	treatment
I-eligibility	1371	1375	with
I-eligibility	1376	1378	no
I-eligibility	1379	1389	metastases
I-eligibility	1390	1392	or
I-eligibility	1393	1403	recurrence
I-eligibility	1404	1407	who
I-eligibility	1408	1414	report
I-eligibility	1415	1419	less
I-eligibility	1420	1424	than
I-eligibility	1425	1427	60
I-eligibility	1428	1435	minutes
I-eligibility	1436	1438	of
I-eligibility	1439	1449	preplanned
I-eligibility	1450	1458	physical
I-eligibility	1459	1467	activity
I-eligibility	1468	1471	per
I-eligibility	1472	1476	week
O	1476	1477	.

O	1478	1482	Both
O	1483	1495	intervention
O	1496	1499	and
O	1500	1507	control
O	1508	1514	groups
O	1515	1522	receive
O	1523	1526	the
O	1527	1529	12
O	1529	1530	-
O	1530	1534	week
O	1535	1543	physical
O	1544	1552	activity
O	1553	1560	program
O	1561	1565	with
O	1566	1572	weekly
O	1573	1578	group
O	1579	1587	sessions
O	1588	1591	and
O	1592	1594	an
O	1595	1609	individualized
O	1609	1610	,
O	1611	1622	progressive
O	1622	1623	,
O	1624	1628	home
O	1628	1629	-
O	1629	1634	based
O	1635	1643	exercise
O	1644	1651	program
O	1651	1652	.

O	1653	1656	The
O	1657	1669	intervention
O	1670	1675	group
O	1676	1680	will
O	1681	1693	additionally
O	1694	1701	receive
O	1702	1703	(
O	1703	1704	1
O	1704	1705	)
O	1706	1708	10
O	1709	1718	telephone
O	1718	1719	-
O	1719	1724	based
O	1725	1731	health
O	1732	1740	coaching
O	1741	1749	sessions
O	1749	1750	,
O	1751	1752	(
O	1752	1753	2
O	1753	1754	)
O	1755	1765	smartphone
O	1766	1770	with
O	1771	1775	data
O	1776	1780	plan
O	1780	1781	,
O	1782	1784	if
O	1785	1791	needed
O	1791	1792	,
O	1793	1794	(
O	1794	1795	3
O	1795	1796	)
O	1797	1807	supportive
O	1808	1814	health
O	1815	1823	tracking
O	1824	1832	software
O	1833	1834	(
O	1834	1843	Connected
O	1844	1852	Wellness
O	1852	1853	,
O	1854	1858	NexJ
O	1859	1865	Health
O	1866	1869	Inc
O	1869	1870	)
O	1870	1871	,
O	1872	1875	and
O	1876	1877	(
O	1877	1878	4
O	1878	1879	)
O	1880	1881	a
O	1882	1890	wearable
O	1891	1895	step
O	1895	1896	-
O	1896	1904	counting
O	1905	1911	device
O	1912	1918	linked
O	1919	1921	to
O	1922	1923	a
O	1924	1934	smartphone
O	1935	1942	program
O	1942	1943	.

O	1944	1946	We
O	1947	1951	will
O	1952	1954	be
O	1955	1964	assessing
O	1965	1976	recruitment
O	1977	1982	rates
O	1982	1983	;
O	1984	1997	acceptability
O	1998	2007	reflected
O	2008	2010	in
O	2011	2020	selective
O	2020	2021	,
O	2022	2036	semistructured
O	2037	2047	interviews
O	2047	2048	;
O	2049	2052	and
O	2053	2063	enrollment
O	2063	2064	,
O	2065	2074	retention
O	2074	2075	,
O	2076	2079	and
O	2080	2089	adherence
O	2090	2102	quantitative
O	2103	2115	intervention
O	2116	2123	markers
O	2124	2126	as
O	2127	2132	pilot
O	2133	2140	outcome
O	2141	2149	measures
O	2149	2150	.

O	2151	2154	The
O	2155	2162	primary
O	2163	2171	clinical
O	2172	2179	outcome
O	2180	2184	will
O	2185	2187	be
O	2188	2196	directly
O	2197	2205	measured
B-outcome-Measure	2206	2210	peak
I-outcome-Measure	2211	2217	oxygen
I-outcome-Measure	2218	2229	consumption
O	2229	2230	.

O	2231	2240	Secondary
O	2241	2249	clinical
O	2250	2258	outcomes
O	2259	2266	include
B-outcome-Measure	2267	2273	health
I-outcome-Measure	2273	2274	-
I-outcome-Measure	2274	2281	related
I-outcome-Measure	2282	2289	quality
I-outcome-Measure	2290	2292	of
I-outcome-Measure	2293	2297	life
O	2298	2301	and
B-outcome-Measure	2302	2316	anthropometric
I-outcome-Measure	2317	2325	measures
O	2325	2326	.

O	2327	2330	All
O	2331	2338	outcome
O	2339	2347	measures
O	2348	2351	are
O	2352	2364	administered
O	2365	2367	at
O	2368	2376	baseline
O	2376	2377	,
O	2378	2383	after
O	2384	2392	exercise
O	2393	2400	program
O	2401	2402	(
O	2402	2407	month
O	2408	2409	3
O	2409	2410	)
O	2410	2411	,
O	2412	2415	and
O	2416	2417	6
O	2418	2424	months
O	2425	2430	after
O	2431	2438	program
O	2439	2440	(
O	2440	2445	month
O	2446	2447	9
O	2447	2448	)
O	2448	2449	.

O	2450	2454	This
O	2455	2460	pilot
O	2461	2464	RCT
O	2465	2469	will
O	2470	2476	inform
O	2477	2481	full
O	2481	2482	-
O	2482	2487	scale
O	2488	2491	RCT
O	2492	2500	planning
O	2500	2501	.

O	2502	2504	We
O	2505	2509	will
O	2510	2516	assess
O	2517	2522	pilot
O	2523	2533	procedures
O	2534	2537	and
O	2538	2551	interventions
O	2552	2555	and
O	2556	2563	collect
O	2564	2575	preliminary
O	2576	2582	effect
O	2583	2592	estimates
O	2592	2593	.

O	2594	2608	ClinicalTrials
O	2608	2609	.
O	2609	2612	gov
O	2613	2624	NCT02620735
O	2624	2625	;
O	2626	2631	https
O	2631	2632	:
O	2632	2633	/
O	2633	2634	/
O	2634	2648	clinicaltrials
O	2648	2649	.
O	2649	2652	gov
O	2652	2653	/
O	2653	2656	ct2
O	2656	2657	/
O	2657	2661	show
O	2661	2662	/
O	2662	2673	NCT02620735
O	2674	2675	(
O	2675	2683	Archived
O	2684	2686	by
O	2687	2694	WebCite
O	2695	2697	at
O	2698	2703	https
O	2703	2704	:
O	2704	2705	/
O	2705	2706	/
O	2706	2720	clinicaltrials
O	2720	2721	.
O	2721	2724	gov
O	2724	2725	/
O	2725	2728	ct2
O	2728	2729	/
O	2729	2733	show
O	2733	2734	/
O	2734	2745	NCT02620735
O	2745	2746	)
O	2746	2747	.
